B. McQuade

1.0k total citations
19 papers, 710 citations indexed

About

B. McQuade is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine. According to data from OpenAlex, B. McQuade has authored 19 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Pathology and Forensic Medicine. Recurrent topics in B. McQuade's work include Nausea and vomiting management (15 papers), Pituitary Gland Disorders and Treatments (4 papers) and Anesthesia and Pain Management (4 papers). B. McQuade is often cited by papers focused on Nausea and vomiting management (15 papers), Pituitary Gland Disorders and Treatments (4 papers) and Anesthesia and Pain Management (4 papers). B. McQuade collaborates with scholars based in United Kingdom, France and United States. B. McQuade's co-authors include Gordon Rustin, ES Newlands, Richard H. J. Beǵent, H. Jürgens, L. Goedhals, W. Paska, J. R. McRae, Colin F. Spraggs, Pierre Diemunsch and P. Schoeffler and has published in prestigious journals such as The Lancet, Annals of Oncology and Anesthesia & Analgesia.

In The Last Decade

B. McQuade

19 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. McQuade United Kingdom 13 571 194 134 122 64 19 710
Denis Dupoiron France 15 240 0.4× 170 0.9× 285 2.1× 148 1.2× 47 0.7× 55 531
Ki‐Wook Chung South Korea 10 556 1.0× 210 1.1× 98 0.7× 62 0.5× 210 3.3× 12 859
Christina H. Ruhlmann Denmark 12 450 0.8× 234 1.2× 48 0.4× 76 0.6× 177 2.8× 42 703
Manish Srivastava India 7 207 0.4× 108 0.6× 103 0.8× 62 0.5× 66 1.0× 26 553
Timothy Melson United States 18 876 1.5× 123 0.6× 613 4.6× 102 0.8× 16 0.3× 25 1.1k
Henry Hu United States 7 304 0.5× 129 0.7× 19 0.1× 75 0.6× 43 0.7× 14 453
Sarah E. Gray United States 8 398 0.7× 225 1.2× 19 0.1× 54 0.4× 57 0.9× 19 494
Pearl Zaki Canada 11 163 0.3× 53 0.3× 58 0.4× 76 0.6× 159 2.5× 19 399
Sonia Fatigoni Italy 10 170 0.3× 124 0.6× 20 0.1× 201 1.6× 344 5.4× 19 673
Simona Parisi Italy 11 305 0.5× 83 0.4× 71 0.5× 12 0.1× 54 0.8× 42 416

Countries citing papers authored by B. McQuade

Since Specialization
Citations

This map shows the geographic impact of B. McQuade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. McQuade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. McQuade more than expected).

Fields of papers citing papers by B. McQuade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. McQuade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. McQuade. The network helps show where B. McQuade may publish in the future.

Co-authorship network of co-authors of B. McQuade

This figure shows the co-authorship network connecting the top 25 collaborators of B. McQuade. A scholar is included among the top collaborators of B. McQuade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. McQuade. B. McQuade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bicket, Mark C., B. McQuade, & Chad M. Brummett. (2021). Opioid Settlement Funds—Do Not Neglect Patients With Pain. JAMA Health Forum. 2(8). e211765–e211765. 2 indexed citations
2.
McQuade, B.. (2018). Smart on Crime Charging Policy Provides Roadmap for More Effective Criminal Justice Strategy. Federal Sentencing Reporter. 30(3). 207–211. 2 indexed citations
4.
Daley‐Yates, Peter T., Claire Ambery, Lisa Sweeney, et al.. (2011). The Efficacy and Tolerability of Two Novel H<sub>1</sub>/H<sub>3</sub> Receptor Antagonists in Seasonal Allergic Rhinitis. International Archives of Allergy and Immunology. 158(1). 84–98. 26 indexed citations
6.
Diemunsch, Pierre, et al.. (1999). Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery. British Journal of Anaesthesia. 82(2). 274–276. 75 indexed citations
7.
Chung, Frances, Roger Lane, Colin F. Spraggs, et al.. (1999). Ondansetron is more effective than metoclopramide for the treatment of opioid-induced emesis in post-surgical adult patients. European Journal of Anaesthesiology. 16(10). 669–677. 10 indexed citations
8.
Krzakowski, Maciej, L. Goedhals, Florence Joly, et al.. (1998). A multicenter, double-blind comparison of i.v. and oral administration of ondansetron plus dexamethasone for acute cisplatin-induced emesis. Anti-Cancer Drugs. 9(7). 593–598. 16 indexed citations
9.
Diemunsch, Pierre, et al.. (1998). ANTIEMETIC ACTIVITY OF THE NK1 RECEPTOR ANTAGONIST GR205171 IN THE TREATMENT OF PONV FOLLOWING MAJOR GYNAECOLOGICAL SURGERY. Anesthesia & Analgesia. 86(2S). 436S–436S. 4 indexed citations
11.
Cunningham, David, M. Dicato, Jaap Verweij, et al.. (1996). Optimum anti-emetic therapy for cisplatin induced emesis over repeat courses: Ondansetron plus dexamethasone compared with metoclopramide, dexamethasone plus lorazepam. Annals of Oncology. 7(3). 277–282. 18 indexed citations
12.
Olver, Ian, W. Paska, A Depierre, et al.. (1996). A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis. Annals of Oncology. 7(9). 945–952. 61 indexed citations
14.
Ruff, Paul, W. Paska, L. Goedhals, et al.. (1994). Ondansetron Compared with Granisetron in the Prophylaxis of Cisplatin-lnduced Acute Emesis: A Multicentre Double-Blind, Randomised, Parallel-Group Study. Oncology. 51(1). 113–118. 90 indexed citations
15.
McQuade, B., et al.. (1993). The efficacy and safety of ondansetron in the prophylaxis of cancer-chemotherapy induced nausea and vomiting in children. Clinical Oncology. 5(1). 11–14. 20 indexed citations
16.
Jürgens, H. & B. McQuade. (1992). Ondansetron as Prophylaxis for Chemotherapy and Radiotherapy-Induced Emesis in Children. Oncology. 49(4). 279–285. 39 indexed citations
17.
Soukop, M., B. McQuade, Alan L. Stewart, et al.. (1992). Ondansetron Compared with Metoclopramide in the Control of Emesis and Quality of Life during Repeated Chemotherapy for Breast Cancer. Oncology. 49(4). 295–304. 69 indexed citations
18.
Rustin, Gordon, et al.. (1991). A Phase II study of ondansetron as antiemetic prophylaxis in patients receiving carboplatin for advanced ovarian cancer. Annals of Oncology. 2(8). 607–608. 6 indexed citations
19.
Newlands, ES, et al.. (1991). Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. The Lancet. 338(8765). 487–490. 157 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026